| Rex Robot Assisted Rehabilitation to Enhance Balance and Mobility for People With Multiple Sclerosis, Clinical and Biomarker Study - RAPPER IV (NCT06429085) | East Kent Hospitals University NHS Foundation Trust | 2018-12-18 |
| Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study (NCT03794011) | Baylor College of Medicine | 2018-12-18 |
| Pharmacokinetics, Efficacy and Safety of the 304 Injection (NCT03980379) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2018-12-18 |
| This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 1358894 Affects the Way the Body Breaks Down Midazolam (NCT03754959) | Boehringer Ingelheim | 2018-12-18 |
| Blinatumomab Expanded T-cells (BET) in Indolent Non-Hodgkin Lymphomas/Chronic Lymphocytic Leukemia (NCT03823365) | A.O. Ospedale Papa Giovanni XXIII | 2018-12-17 |
| A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RO7017773 in Healthy Participants (NCT03774576) | Hoffmann-La Roche | 2018-12-17 |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03677960) | Antiva Biosciences | 2018-12-17 |
| Spinal Excitation to Enhance Mobility (NCT03667573) | VA Office of Research and Development | 2018-12-17 |
| Study of Ascending Single Oral Dose of GT-002 in Healthy Volunteers (NCT03817346) | Gabather AB | 2018-12-17 |
| AAV2/8-LSPhGAA (ACTUS-101) in Late-Onset Pompe Disease (NCT03533673) | AskBio Inc | 2018-12-17 |
| Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML) (NCT03388749) | Moleculin Biotech, Inc. | 2018-12-17 |
| Pharmacological Intervention for Symptomatic Snoring (NCT03720353) | Brigham and Women's Hospital | 2018-12-17 |
| Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors (NCT03689192) | Herlev Hospital | 2018-12-17 |
| FOCUS: A Phase I/II First in Human Study to Evaluate the Safety and Efficacy of GT005 Administered in Subjects With Dry AMD (NCT03846193) | Gyroscope Therapeutics Limited | 2018-12-17 |
| Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia (NCT03634228) | M.D. Anderson Cancer Center | 2018-12-17 |
| A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PHP-303 in Otherwise Healthy Overweight or Obese Subjects (NCT03775278) | pH Pharma | 2018-12-17 |
| Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP) (NCT02932956) | Baylor College of Medicine | 2018-12-17 |
| Study to Compare Safety and Pharmacokinetics of "CG1801" and "CGL1802" in Healthy Volunteers (NCT03774355) | CrystalGenomics, Inc. | 2018-12-17 |
| Norepinephrine Boluses in Liver Transplantation (NCT03773276) | Mansoura University | 2018-12-17 |
| Adipose Stem/Stromal Cells in RSD, CRPS, Fibromyalgia (NCT02987855) | Healeon Medical Inc | 2018-12-15 |
| Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer (NCT03507699) | Sheba Medical Center | 2018-12-15 |
| Use of Cellular Stromal Vascular Fraction in Multiple Sclerosis,Autoimmune, Inflammatory, Neurologic Conditions (NCT02939859) | Healeon Medical Inc | 2018-12-15 |
| CPX-351 (Vyxeos™) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome (NCT03572764) | Washington University School of Medicine | 2018-12-14 |
| A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Rifampin Capsules (NCT03758469) | Sichuan Haisco Pharmaceutical Group Co., Ltd | 2018-12-14 |
| A Study of the Safety and Tolerability of CDX-6114 in Healthy Volunteers (NCT03797664) | Codexis Inc. | 2018-12-14 |
| Evaluating the Pharmacokinetic Characteristics of AD-101 in Healthy Volunteers (NCT03764462) | Addpharma Inc. | 2018-12-14 |
| A Study of RO7239958 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection (NCT03762681) | Hoffmann-La Roche | 2018-12-14 |
| A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies (NCT03789617) | Eutilex | 2018-12-14 |
| A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer (NCT03498196) | Baylor College of Medicine | 2018-12-14 |
| Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis (NCT03757351) | Sanofi | 2018-12-14 |
| A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers (NCT03778320) | Concert Pharmaceuticals | 2018-12-14 |
| Continued Access to RXDX-105 (NCT03784378) | Memorial Sloan Kettering Cancer Center | 2018-12-14 |
| A Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic Fibrosis (NCT03647228) | Ionis Pharmaceuticals, Inc. | 2018-12-13 |
| Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid Tumors (NCT03684785) | Exicure, Inc. | 2018-12-13 |
| Stem Cells Therapy in Degenerative Diseases of the Retina (NCT03772938) | Pomeranian Medical University Szczecin | 2018-12-13 |
| A Safety Study of LY3462817 in Healthy Participants (NCT03715192) | Eli Lilly and Company | 2018-12-13 |
| A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors (NCT03797391) | Shanghai EpimAb Biotherapeutics Co., Ltd. | 2018-12-13 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma (NCT03821363) | Sinocelltech Ltd. | 2018-12-13 |
| VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma (NCT03769155) | Emory University | 2018-12-13 |
| The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers Volunteers (NCT03707899) | Jeil Pharmaceutical Co., Ltd. | 2018-12-13 |
| Study of APVO436 in Patients With AML or MDS (NCT03647800) | Aptevo Research and Development LLC | 2018-12-13 |
| A Study in Healthy Volunteers Investigating How Quickly and to What Extent BAY1817080 is Taken up, Distributed, Broken Down and Eliminated From the Body, as Well as the Difference Between 2 Different Types of Tablets of BAY1817080 and the Difference Between Oral Dose and Dose in the Vein (NCT03773068) | Bayer | 2018-12-13 |
| A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis (NCT03817424) | Amgen | 2018-12-13 |
| Near-Infrared Image Guided Surgical Resection With Indocyanine Green in Treating Patients With Head and Neck Cancer (NCT03745690) | Jonsson Comprehensive Cancer Center | 2018-12-12 |
| Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA) (NCT04494191) | Genuine Research Center, Egypt | 2018-12-12 |
| Milademetan Plus Quizartinib Combination Study in FLT3-ITD Mutant Acute Myeloid Leukemia (AML) (NCT03552029) | Daiichi Sankyo | 2018-12-12 |
| Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients (NCT03765671) | Genfit | 2018-12-12 |
| Transplanting Hepatitis C Lungs Into Negative Lung Recipients (NCT03724149) | University of Pennsylvania | 2018-12-12 |
| Multi-antigen T Cell Infusion Against Neuro-oncologic Disease (NCT03652545) | Catherine Bollard | 2018-12-12 |
| A Study of 99mTc-3PRGD2 Injection in Healthy Volunteers (NCT03974685) | RDO Pharm. | 2018-12-12 |
| Safety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered Tumors (NCT03780517) | Boston Pharmaceuticals | 2018-12-12 |
| Study With Lu AF20513 in Patients With Mild Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI) Due to AD (NCT03819699) | H. Lundbeck A/S | 2018-12-12 |
| MGD019 DART® Protein in Unresectable/Metastatic Cancer (NCT03761017) | MacroGenics | 2018-12-12 |
| A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients (NCT03751488) | Luye Pharma Group Ltd. | 2018-12-12 |
| MAD Phase I Study to Investigate Contraloid Acetate (NCT03955380) | Prof. Dr. Dieter Willbold | 2018-12-12 |
| Dexamethasone Implant for Retinal Detachment in Uveal Melanoma (NCT04082962) | Ivana K. Kim | 2018-12-11 |
| A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients (NCT03815695) | Forma Therapeutics, Inc. | 2018-12-11 |
| A Study of LY3451838 in Healthy Participants (NCT03692949) | Eli Lilly and Company | 2018-12-11 |
| A Study of Isatuximab-based Therapy in Participants With Lymphoma (NCT03769181) | Sanofi | 2018-12-11 |
| The Study of Multiple Doses of CM-101 in Male and Female NAFLD (Nonalcoholic Fatty Liver Disease) and NAFLD/NASH (Nonalcoholic Steatohepatitis) Subjects (NCT06044467) | ChemomAb Ltd. | 2018-12-11 |
| Cetirizine Chewable Bioequivalence and Food Effect Study (NCT03772158) | Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | 2018-12-11 |
| Pharmacokinetic and Safety Comparison of Two Capecitabine Tablets in Patients With Colorectal or Breast Cancer (NCT04420871) | The Affiliated Hospital of Qingdao University | 2018-12-10 |
| VAccination in Early and ADvanced Prostate caNCEr (NCT03815942) | University of Oxford | 2018-12-10 |
| Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers. (NCT03798236) | Palobiofarma SL | 2018-12-10 |
| Safety, PK, and PD Study of a Vaginal Insert Containing TAF and EVG (NCT03762772) | CONRAD | 2018-12-10 |
| Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine (NCT03762785) | Assiut University | 2018-12-10 |
| A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430 (NCT03800173) | BioCryst Pharmaceuticals | 2018-12-10 |
| A Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors (NCT03762447) | Incyte Corporation | 2018-12-10 |
| Pharmacokinetics and Pharmacological Effects of a Standardized Cannabis Preparation (NCT04841993) | Germans Trias i Pujol Hospital | 2018-12-10 |
| A Study of Effects of Selpercatinib in Hepatically Impaired Participants and Healthy Participants (NCT05436912) | Eli Lilly and Company | 2018-12-10 |
| Ultra-high Dose Vitamin D for HSCT (NCT03759262) | Children's Hospital Los Angeles | 2018-12-10 |
| Single Dose Study With Unlabeled Dose and 14C-labeled Microdose of PF-06700841 in Healthy Male Subjects (NCT03770039) | Pfizer | 2018-12-10 |
| Cannabidiol - an in Vivo Innovative Drug Delivery Study (NCT03471559) | Central Institute of Mental Health, Mannheim | 2018-12-10 |
| Comparison of Aramchol Concentrations With Once or Twice Daily Dosing (NCT03774173) | Galmed Pharmaceuticals Ltd | 2018-12-08 |
| A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis (NCT03775434) | AOBiome LLC | 2018-12-07 |
| Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH (NCT02997878) | University of Birmingham | 2018-12-07 |
| SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects (NCT03669614) | Aridis Pharmaceuticals, Inc. | 2018-12-07 |
| ESTIMATION OF THE EFFECT OF MULTIPLE DOSE PF-06651600 ON THE PHARMACOKINETICS OF SINGLE DOSE MIDAZOLAM AND EFAVIRENZ (NCT03762928) | Pfizer | 2018-12-07 |
| A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week (NCT03766854) | Novo Nordisk A/S | 2018-12-07 |
| CPI-613 in Combination With Modified FOLFIRINOX in Locally Advanced Pancreatic Cancer (NCT03699319) | David Bajor, MD | 2018-12-07 |
| Lentivirally Redirected CD123 Autologous T Cells in AML (NCT03766126) | University of Pennsylvania | 2018-12-06 |
| Effects of Tucatinib on Cardiac Repolarization in Healthy Participants (NCT03777761) | Seagen Inc. | 2018-12-06 |
| Safety and Tolerability of an Antibody Against Yellow Fever Virus (TY014) in Humans (NCT03776786) | Tysana Pte Ltd | 2018-12-06 |
| Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC (NCT03706287) | Sichuan Cancer Hospital and Research Institute | 2018-12-06 |
| A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib (NCT03587363) | Janssen Research & Development, LLC | 2018-12-06 |
| NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma (NCT03549715) | Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 2018-12-06 |
| Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies (NCT03790488) | Jounce Therapeutics, Inc. | 2018-12-06 |
| A Study to Evaluate the Effect of Cyclosporine, a P-Glycoprotein, Breast Cancer Resistance Protein, and Organic-Anion-Transporting Polypeptide Inhibitor, on Pimodivir in Healthy Adults (NCT03768609) | Janssen-Cilag International NV | 2018-12-06 |
| A Study of LY3463251 in Healthy Participants (NCT03764774) | Eli Lilly and Company | 2018-12-06 |
| Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer (NCT03639246) | Aravive, Inc. | 2018-12-06 |
| Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET) (NCT03635411) | Elysium Health | 2018-12-06 |
| A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects (NCT03742882) | Celgene | 2018-12-06 |
| Bioequivalence Study in Healthy Subjects by Using of Chlorpromazine HCl 100mg Tablets (NCT06154434) | Whanin Pharmaceutical Company | 2018-12-06 |
| A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea (NCT03793686) | Prolacta Bioscience | 2018-12-06 |
| Spironolactone Versus Prednisolone in DMD (NCT03777319) | Kevin Flanigan | 2018-12-05 |
| Study to Assess Bioequivalence of a New Nifurtimox Oral Tablet Formulation (NCT03708133) | Bayer | 2018-12-05 |
| A Randomized, Double-blind, Placebo-controlled Study of Delandistrogene Moxeparvovec (SRP-9001) for Duchenne Muscular Dystrophy (DMD) (NCT03769116) | Sarepta Therapeutics, Inc. | 2018-12-05 |
| Pembrolizumab in Combination with Bevacizumab and Pegylated Liposomal Doxorubicin in Patients with Ovarian Cancer (NCT03596281) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-12-05 |
| A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma (NCT03767751) | Chinese PLA General Hospital | 2018-12-05 |
| Paricalcitol Plus Gemcitabine and Nab-paclitaxel in Metastatic Pancreatic Cancer (NCT03520790) | Dana-Farber Cancer Institute | 2018-12-05 |